[Analgesic effects of Emla cream and saccharose solution for subcutaneous injections in preterm newborns: a prospective study of 265 injections]

Arch Pediatr. 2004 Aug;11(8):921-5. doi: 10.1016/j.arcped.2004.03.028.
[Article in French]

Abstract

Objective: To compare the analgesic effects of non nutritive pacifier sucking, oral administration of a 30% saccharose solution, local application of Emla and their association for subcutaneous injection of erythropoietin (EPO) in preterm infants.

Methods: Our study was a randomised, prospective study conducted over 5 months. Neonates with a gestational age below 33 weeks of gestation and older than 8 days of life were included if they were treated with EPO (three subcutaneous injections per week during 6 weeks). For each consecutive EPO injection, patients were randomised between four groups of intervention: non nutritive pacifier sucking (T), oral administration of 0.2-0.5 ml of a 30% saccharose solution with non nutritive pacifier sucking (S), local application of Emla with non nutritive pacifier sucking (E), and oral administration of 0.2-0.5 ml of a 30% saccharose solution with local application of Emla and with non nutritive pacifier sucking (S + E). Each child was its own control. Pain was assessed with the Newborn Acute Pain scale (DAN) and with the Neonatal Facial Coding System (NFCS).

Results: Thirty-three neonates were included, representing 265 injections. Distribution was: 41 in group T, 71 in group E, 86 in group S and 67 in group E + S. Mean DAN and NFCS scores were statistically different between groups T, E and S. Analgesic effect of saccharose (-1.05) was greater than Emla (-0.56). Used together, effects were adding up without potentialisation.

Conclusion: This study shows that the association of non nutritive pacifier sucking with oral administration of saccharose and local application of Emla has a better analgesic effect than each of these three interventions alone for subcutaneous injection of EPO.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Administration, Cutaneous
  • Administration, Oral
  • Analysis of Variance
  • Anesthetics, Combined / therapeutic use*
  • Anesthetics, Local / therapeutic use*
  • Combined Modality Therapy
  • Drug Therapy, Combination
  • Erythropoietin / administration & dosage
  • Facial Expression
  • Female
  • Gestational Age
  • Humans
  • Infant, Newborn
  • Infant, Premature, Diseases / diagnosis
  • Infant, Premature, Diseases / etiology
  • Infant, Premature, Diseases / prevention & control*
  • Injections, Subcutaneous / adverse effects*
  • Lidocaine / therapeutic use*
  • Lidocaine, Prilocaine Drug Combination
  • Male
  • Pacifiers / standards*
  • Pain / diagnosis
  • Pain / etiology
  • Pain / prevention & control*
  • Pain Measurement / methods
  • Prilocaine / therapeutic use*
  • Prospective Studies
  • Solutions
  • Sucking Behavior
  • Sucrose / therapeutic use*
  • Treatment Outcome

Substances

  • Anesthetics, Combined
  • Anesthetics, Local
  • Lidocaine, Prilocaine Drug Combination
  • Solutions
  • Prilocaine
  • Erythropoietin
  • Sucrose
  • Lidocaine